High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study

British Journal of Haematology

Volumn 152, Issue 5, 2011, Pages 600-610

  Eide, Marianne B ^a,b,c   Lauritzsen, Grete F ^d   Kvalheim, Gunnar ^e   Kolstad, Arne ^d   Fagerli, Unn M ^f   Maisenhölder, Martin ^g   Østenstad, Bjørn ^d   Fluge, Øystein ^h   Delabie, Jan ^e   Aarset, Harald ^f   Liestøl, Knut ⁱ   Holte, Harald ^d  

^a Centre for Cancer Biomedicine   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c Institute for Cancer Research   (Norway)

^d Division of Cancer Medicine and Surgery   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^g UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^h HAUKELAND UNIVERSITY HOSPITAL   (Norway)

ⁱ UNIVERSITY OF OSLO   (Norway)

Author keywords

Autologous stem cell support; Diffuse large B cell lymphoma; Follicular lymphoma; High dose therapy; Transformation

Indexed keywords

CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOGUAZONE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NORWAY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; RISK ASSESSMENT; STEM CELL MOBILIZATION; TREATMENT RESPONSE; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW PURGING; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; EPIDEMIOLOGIC METHODS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; RECURRENCE; SALVAGE THERAPY; TISSUE AND ORGAN HARVESTING; TREATMENT OUTCOME;

EID: 79951553356     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08519.x     Document Type: Article

References (49)

1. Acker, B., Hoppe, R.T., Colby, T.V., Cox, R.S., Kaplan, H.S. & Rosenberg, S.A. (1983) Histologic conversion in the non-Hodgkin's lymphomas. Journal of Clinical Oncology, 1, 11-16.
2. +-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections. Experimental Hematology, 30, 824-830.
3. Al-Tourah, A.J., Gill, K.K., Chhanabhai, M., Hoskins, P.J., Klasa, R.J., Savage, K.J., Sehn, L.H., Shenkier, T.N., Gascoyne, R.D. & Connors, J.M. (2008) Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma. Journal of Clinical Oncology, 26, 5165-5169.
4. Andreadis, C., Schuster, S.J., Chong, E.A., Svoboda, J., Luger, S.M., Porter, D.L., Tsai, D.E., Nasta, S.D., Elstrom, R.L., Goldstein, S.C., Downs, L.H., Mangan, P.A., Cunningham, K.A., Hummel, K.A., Gimotty, P.A., Siegel, D.L., Glatstein, E. & Stadtmauer, E.A. (2005) Long-term event-free survivors after high-dose therapy and autologous stem-cell transplantation for low-grade follicular lymphoma. Bone Marrow Transplantation, 36, 955-961.
5. Armitage, J.O., Carbone, P.P., Connors, J.M., Levine, A., Bennett, J.M. & Kroll, S. (2003) Treatment-Related Myelodysplasia and Acute Leukemia in Non-Hodgkin's Lymphoma Patients. Journal of Clinical Oncology, 21, 897-906.
6. Aurlien, E., Holte, H., Pharo, A., Kvaloy, S., Jakobsen, E., Smeland, E.B. & Kvalheim, G. (1998) Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma. Bone Marrow Transplantation, 21, 873-878.
7. Aurlien, E., Holte, H., Kvaloy, S., Jakobsen, E., Rusten, L.S. & Kvalheim, G. (2001) Combination chemotherapy containing mitoguazone, ifosfamide, methotrexate, etoposide (MIME) and G-CSF efficiently mobilize peripheral blood progenitor cells in heavily pre-treated relapsed lymphoma patients. European Journal of Haematology. Supplementum, 64, 14-20.
8. Bastion, Y., Brice, P., Haioun, C., Sonet, A., Salles, G., Marolleau, J.P., Espinouse, D., Reyes, F., Gisselbrecht, C. & Coiffier, B. (1995) Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood, 86, 3257-3262.
9. Bastion, Y., Sebban, C., Berger, F., Felman, P., Salles, G., Dumontet, C., Bryon, P.A. & Coiffier, B. (1997) Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients. Journal of Clinical Oncology, 15, 1587-1594.
10. Berglund, A., Enblad, G., Carlson, K., Glimelius, B. & Hagberg, H. (2000) Long-term follow-up of autologous stem-cell transplantation for follicular and transformed follicular lymphoma. European Journal of Haematology, 65, 17-22.
11. Bernstein, S.H. & Burack, W.R. (2009) The incidence, natural history, biology, and treatment of transformed lymphomas. Hematology/the Education Program of the American Society of Hematology, 532-541.
12. Bierman, P.J., Sweetenham, J.W., Loberiza, F.R. Jr, Taghipour, G., Lazarus, H.M., Rizzo, J.D., Schmitz, N., van Besien, K., Vose, J.M., Horowitz, M. & Goldstone, A. (2003) Syngeneic hematopoietic stem-cell transplantation for non-Hodgkin's lymphoma: a comparison with allogeneic and autologous transplantation - The Lymphoma Working Committee of the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology, 21, 3744-3753.
13. Blystad, A.K., Holte, H., Kvaloy, S., Smeland, E., Delabie, J. & Kvalheim, G. (2001) High-dose therapy in patients with Hodgkin's disease: the use of selected CD34(+) cells is as safe as unmanipulated peripheral blood progenitor cells. Bone Marrow Transplantation, 28, 849-857.
14. Blystad, A.K., Delabie, J., Kvaloy, S., Holte, H., Valerhaugen, H., Ikonomou, I. & Kvalheim, G. (2004) Infused CD34 cell dose, but not tumour cell content of peripheral blood progenitor cell grafts, predicts clinical outcome in patients with diffuse large B-cell lymphoma and follicular lymphoma grade 3 treated with high-dose therapy. British Journal of Haematology, 125, 605-612.
15. + cells from non-Hodgkin's lymphoma, Hodgkin's disease and multiple myeloma patients previously failing mobilization with chemotherapy and/or cytokine treatment: compassionate use data. Bone Marrow Transplantation, 41, 331-338.
16. Cao, T.M., Horning, S., Negrin, R.S., Hu, W.W., Johnston, L.J., Taylor, T.L., Shizuru, J.A., Hoppe, R.T., Brown, B.W., Blume, K.G. & Stockerl-Goldstein, K.E. (2001) High-dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience. Biology of Blood and Marrow Transplantation, 7, 294-301.
17. Chen, C.I., Crump, M., Tsang, R., Stewart, A.K. & Keating, A. (2001) Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. British Journal of Haematology, 113, 202-208.
18. Fisher, S.G. & Fisher, R.I. (2004) The epidemiology of non-Hodgkin's lymphoma. Oncogene, 23, 6524-6534.
19. Foran, J.M., Apostolidis, J., Papamichael, D., Norton, A.J., Matthews, J., Amess, J.A., Lister, T.A. & Rohatiner, A.Z. (1998) High-dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Annals of Oncology, 9, 865-869.
20. Friedberg, J.W., Neuberg, D., Gribben, J.G., Mauch, P., Anderson, K.C., Soiffer, R.J., Takvorian, T., Fisher, D.C., Schlossman, R., Jallow, H., Kuhlman, C., Ritz, J. & Freedman, A.S. (1999) Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. Biology of Blood and Marrow Transplantation, 5, 262-268.
21. + enriched peripheral blood progenitor cell (PBPC) transplantation is associated with higher morbidity in patients with lymphoma when compared to unmanipulated PBPC transplantation. Bone Marrow Transplantation, 26, 831-836.
22. Garvin, A.J., Simon, R.M., Osborne, C.K., Merrill, J., Young, R.C. & Berard, C.W. (1983) An autopsy study of histologic progression in non-Hodgkin's lymphomas. 192 cases from the National Cancer Institute. Cancer, 52, 393-398.
23. Gine, E., Montoto, S., Bosch, F., Arenillas, L., Mercadal, S., Villamor, N., Martinez, A., Colomo, L., Campo, E., Montserrat, E. & Lopez-Guillermo, A. (2006) The Follicular Lymphoma International Prognostic Index (FLIPI) and the histological subtype are the most important factors to predict histological transformation in follicular lymphoma. Annals of Oncology, 17, 1539-1545.
24. Gordan, L.N., Sugrue, M.W., Lynch, J.W., Williams, K.D., Khan, S.A. & Moreb, J.S. (2003a) Correlation of early lymphocyte recovery and progression-free survival after autologous stem-cell transplant in patients with Hodgkin's and non-Hodgkin's Lymphoma. Bone Marrow Transplantation, 31, 1009-1013.
25. Gordan, L.N., Sugrue, M.W., Lynch, J.W., Williams, K.D., Khan, S.A., Wingard, J.R. & Moreb, J.S. (2003b) Poor mobilization of peripheral blood stem cells is a risk factor for worse outcome in lymphoma patients undergoing autologous stem cell transplantation. Leukemia & Lymphoma, 44, 815-820.
26. Haas, R., Mohle, R., Fruhauf, S., Goldschmidt, H., Witt, B., Flentje, M., Wannenmacher, M. & Hunstein, W. (1994) Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood, 83, 3787-3794.
27. Hamadani, M., Benson, D.M. Jr, Lin, T.S., Porcu, P., Blum, K.A. & Devine, S.M. (2008) High-dose therapy and autologous stem cell transplantation for follicular lymphoma undergoing transformation to diffuse large B-cell lymphoma. European Journal of Haematology, 81, 425-431.
28. Horning, S.J. & Rosenberg, S.A. (1984) The natural history of initially untreated low-grade non-Hodgkin's lymphomas. The New England Journal of Medicine, 311, 1471-1475.
29. Ketterer, N., Salles, G., Moullet, I., Dumontet, C., ElJaafari-Corbin, A., Tremisi, P., Thieblemont, C., Durand, B., Neidhardt-Berard, E.M., Samaha, H., Rigal, D. & Coiffier, B. (1998) Factors associated with successful mobilization of peripheral blood progenitor cells in 200 patients with lymphoid malignancies. British Journal of haematology, 103, 235-242.
30. + cells. Blood Therapies in Medicine, 2, 57-64.
31. Kvalheim, G., Wang, M.Y., Pharo, A., Holte, H., Jacobsen, E., Beiske, K., Kvaloy, S., Smeland, E., Funderud, S. & Fodstad, O. (1996) Purging of tumor cells from leukapheresis products: experimental and clinical aspects. Journal of Hematotherapy, 5, 427-436.
32. Montoto, S., Davies, A.J., Matthews, J., Calaminici, M., Norton, A.J., Amess, J., Vinnicombe, S., Waters, R., Rohatiner, A.Z. & Lister, T.A. (2007a) Risk and clinical implications of transformation of follicular lymphoma to diffuse large B-cell lymphoma. Journal of Clinical Oncology, 25, 2426-2433.
33. Montoto, S., Canals, C., Rohatiner, A.Z., Taghipour, G., Sureda, A., Schmitz, N., Gisselbrecht, C., Fouillard, L., Milpied, N., Haioun, C., Slavin, S., Conde, E., Fruchart, C., Ferrant, A., Leblond, V., Tilly, H., Lister, T.A. & Goldstone, A.H. (2007b) Long-term follow-up of high-dose treatment with autologous haematopoietic progenitor cell support in 693 patients with follicular lymphoma: an EBMT registry study. Leukemia, 21, 2324-2331.
34. Moskowitz, C.H., Glassman, J.R., Wuest, D., Maslak, P., Reich, L., Gucciardo, A., Coady-Lyons, N., Zelenetz, A.D. & Nimer, S.D. (1998) Factors affecting mobilization of peripheral blood progenitor cells in patients with lymphoma. Clinical Cancer Research, 4, 311-316.
35. Pavone, V., Gaudio, F., Console, G., Vitolo, U., Iacopino, P., Guarini, A., Liso, V., Perrone, T. & Liso, A. (2006) Poor mobilization is an independent prognostic factor in patients with malignant lymphomas treated by peripheral blood stem cell transplantation. Bone Marrow Transplantation, 37, 719-724.
36. Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van Der Lelie, H., Bron, D., Sonneveld, P., Gisselbrecht, C., Cahn, J.Y., Harousseau, J.L., Coiffier, B., Biron, P., Mandelli, F. & Chauvin, F. (1995) Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma. The New England Journal of Medicine, 333, 1540-1545.
37. Porrata, L.F., Gertz, M.A., Inwards, D.J., Litzow, M.R., Lacy, M.Q., Tefferi, A., Gastineau, D.A., Dispenzieri, A., Ansell, S.M., Micallef, I.N., Geyer, S.M. & Markovic, S.N. (2001) Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma. Blood, 98, 579-585.
38. Porrata, L.F., Inwards, D.J., Ansell, S.M., Micallef, I.N., Johnston, P.B., Gastineau, D.A., Litzow, M.R., Winters, J.L. & Markovic, S.N. (2008) Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. Biology of Blood and Marrow Transplantation, 14, 807-816.
39. Sabloff, M., Atkins, H.L., ce-Bruckler, I., Bredeson, C., Fergusson, D., Genest, P., Hopkins, H., Hutton, B., Mcdiarmid, S. & Huebsch, L.B. (2007) A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma. Biology of Blood and Marrow Transplantation, 13, 956-964.
40. Schouten, H.C., Bierman, P.J., Vaughan, W.P., Kessinger, A., Vose, J.M., Weisenburger, D.D. & Armitage, J.O. (1989) Autologous bone marrow transplantation in follicular non-Hodgkin's lymphoma before and after histologic transformation. Blood, 74, 2579-2584.
41. Schouten, H.C., Qian, W., Kvaloy, S., Porcellini, A., Hagberg, H., Johnsen, H.E., Doorduijn, J.K., Sydes, M.R. & Kvalheim, G. (2003) High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial. Journal of Clinical Oncology, 21, 3918-3927.
42. Shaulov, A., Yue, S., Wang, R., Joyce, R.M., Balk, S.P., Kim, H.T., Avigan, D.E., Uhl, L., Sackstein, R. & Exley, M.A. (2008) Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival. Experimental Hematology, 36, 464-472.
43. Shipp, M.A., Abeloff, M.D., Antman, K.H., Carroll, G., Hagenbeek, A., Loeffler, M., Montserrat, E., Radford, J.A., Salles, G., Schmitz, N., Symann, M., Armitage, J.O., Philip, T. & Coiffier, B. (1999) International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the Jury. Journal of Clinical Oncology, 17, 423.
44. Stiff, P., Chen, B., Franklin, W., Oldenberg, D., Hsi, E., Bayer, R., Shpall, E., Douville, J., Mandalam, R., Malhotra, D., Muller, T., Armstrong, R.D. & Smith, A. (2000) Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood, 95, 2169-2174.
45. Swerdlow, S.H., Campo, E., Harris, N.L., Jaffe, E.S., Pileri, S.A., Stein, H., Thiele, J. & Vardiman, J.W. (2008). WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues, 4th edn. IARC Press, Lyon, France.
46. + cell dose predicts shortened progression free and overall survival after autologous HSCT for lymphoma. Bone Marrow Transplantation, 40, 111-118.
47. Williams, C.D., Goldstone, A.H., Pearce, R.M., Philip, T., Hartmann, O., Colombat, P., Santini, G., Foulard, L. & Gorin, N.C. (1996) Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin's lymphoma: a case-matched comparison with unpurged cases by the European Blood and Marrow Transplant Lymphoma Registry. Journal of Clinical Oncology, 14, 2454-2464.
48. Williams, C.D., Harrison, C.N., Lister, T.A., Norton, A.J., Blystad, A.K., Coiffier, B., Taghipour, G., Schmitz, N. & Goldstone, A.H. (2001) High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry. Journal of Clinical Oncology, 19, 727-735.
49. Yuen, A.R., Kamel, O.W., Halpern, J. & Horning, S.J. (1995) Long-term survival after histologic transformation of low-grade follicular lymphoma. Journal of Clinical Oncology, 13, 1726-1733.